ࡱ> {` <bjbjFF Y,,#Pf*,*,*,@j-/f`/ 7" 8 8 8 8;=a_c_c_c_c_c_c_$ahd|_> 8 8>>_ 8 8h`DJDJDJ> 8 8a_DJ>a_DJDJUWX 8/ пZ*,NCWZ~`0`W~dC ~d(X~dXDJ>>>__IX>>>`>>>>fff$*,fff*,fff Appendix 1 - Antibody Production 1. Monoclonal Antibody Production: Will monoclonal antibodies be produced in animals or harvested from hybridoma cell lines as part of this project?  FORMCHECKBOX  No. Proceed to item 3.  FORMCHECKBOX  Yes. Complete item 1.a. a. Is antibody harvest limited to existing hybridoma cell lines with no further immunizations or lymphocyte fusions planned?  FORMCHECKBOX  Yes. Proceed to item 2 below.  FORMCHECKBOX  No. Fill out items 1.b and 1.c below; then proceed to item 2. b. Complete the following table regarding the immunization protocol for the animals prior to lymphocyte harvest for hybridoma creation. For each antigen for which multiple immunization days will be used, use a separate row in the table for each immunization day. TABLE 1 MONOCLONAL ANTIBODYInjection day (e.g. day 0, 7, 30, etc.)AntigenAdjuvantAmount antigenTotal injection volume Number of divided injections Injection route and anatomical location (e.g., SC, dorsum) FORMTEXT       FORMTEXT       FORMTEXT       FORMTEXT       mg FORMTEXT       mL FORMTEXT       FORMTEXT       FORMTEXT       FORMTEXT       FORMTEXT       FORMTEXT       mg FORMTEXT       mL FORMTEXT       FORMTEXT       FORMTEXT       FORMTEXT       FORMTEXT       FORMTEXT       mg FORMTEXT       mL FORMTEXT       FORMTEXT       c. If feeder cells for supporting hybridoma colony growth will be collected from animals, describe the exact procedures that will be used to collect the feeder cells and the number of animals needed for this purpose.  FORMTEXT       2. Alternatives: Consider alternate research methods that can replace the use of animals. Will any animals be used to expand hybridoma cell lines so that antibody can be harvested from ascites fluid?  FORMCHECKBOX  No. Proceed to item 2.d.  FORMCHECKBOX  Yes. Complete items 2.a-2.c below; then proceed to item 2.d. a. Explain why in vitro cell culture systems for harvesting monoclonal antibodies are not adequate to meet the research objectives.  FORMTEXT       b. Complete the following table. TABLE 2  HYBRIDOMA CELL LINESHybridoma cell line designationNumber of animals used for ascites productionPriming agent and volume(mL)Number and timing of priming injectionsVolume of injected hybridoma cells (mL)Number of abdominal taps before euthanasia FORMTEXT       FORMTEXT       FORMTEXT       mL FORMTEXT       FORMTEXT       mL FORMTEXT       FORMTEXT       FORMTEXT       FORMTEXT       mL FORMTEXT       FORMTEXT       mL FORMTEXT       FORMTEXT       FORMTEXT       FORMTEXT       mL FORMTEXT       FORMTEXT       mL FORMTEXT       c. Euthanasia: What criteria will be used to determine the terminal abdominal tap?  FORMTEXT       d. Blood collection: Will survival blood collections be obtained from animals following immunization or as a  pre-bleed prior to immunization?  FORMCHECKBOX  No. Proceed to item 3.  FORMCHECKBOX  Yes. Complete items i) and ii) below; then proceed to item 3. i) Complete the following table; include any pre-bleeds prior to immunizations. TABLE 3 BLOOD COLLECTIONSite of blood collection*Amount of blood collected expressed as volume (mL)/ and % of body weight (assume 1 ml = 1 gram)Number of blood collectionsInterval between collections FORMTEXT       FORMTEXT       mL/  FORMTEXT       % FORMTEXT       FORMTEXT       weeks FORMTEXT       FORMTEXT       mL/  FORMTEXT       % FORMTEXT       FORMTEXT       weeks FORMTEXT       FORMTEXT       mL/  FORMTEXT       % FORMTEXT       FORMTEXT       weeks * To approximate acceptable blood collection volumes, assume the total blood volume of a healthy animal as 7% of its body weight, and that 10% of the total blood volume can be collected every 2 weeks without causing significant physiological change. (Example: acceptable blood volume for a 30 g mouse ( 0.07 X 30 g X 0.10 = .21 mL.) Blood volumes in excess of 10% will be considered with scientific justification. Typically the maximum blood available for a terminal procedure is 50% of blood volume MUST be taken with the animal under anesthesia. ii) Will anesthetics, tranquilizers, or analgesics be used prior to blood collection?  FORMCHECKBOX  No. Justify the omission of pain-relieving agents below; then proceed to item 3.  FORMCHECKBOX  Yes. Describe the administration of pain-relieving agents including dose (mg/kg), volume (mL), route, and frequency/duration; then proceed to item 3.  FORMTEXT       3. Polyclonal Antibody Production: Will polyclonal antibodies be produced in this species of animal as a part of this project?  FORMCHECKBOX  No. Do not complete items 3.a.-3.c. Go to item 4 below.  FORMCHECKBOX  Yes. Complete items 3.a.-3.c., then go to item 4. Complete the following table. For each antigen for which multiple immunization days will be used. Use a separate row in the table for each day. TABLE 4 POLYCLONAL ANTIBODYInjection day (e.g. day 0, 7, 30, etc.)AntigenAdjuvantAmount antigenTotal injection volume Number of divided injections Injection route and anatomical location (e.g., SC, dorsum) FORMTEXT       FORMTEXT       FORMTEXT       FORMTEXT       mg FORMTEXT       mL FORMTEXT       FORMTEXT       FORMTEXT       FORMTEXT       FORMTEXT       FORMTEXT       mg FORMTEXT       mL FORMTEXT       FORMTEXT       FORMTEXT       FORMTEXT       FORMTEXT       FORMTEXT       mg FORMTEXT       mL FORMTEXT       FORMTEXT       b. List possible adverse effects in animals that might be seen from the proposed antigen or adjuvant injections and what measures will be taken should these adverse effects occur.  FORMTEXT         %CD ϾϘπϘhdLϘ/jh h CJOJQJU^JaJh{/jth h CJOJQJU^JaJ/jh h CJOJQJU^JaJ#jh{CJOJQJU^JaJ&h=h=5CJOJQJ\^JaJ h{5CJOJQJ\^JaJh{CJOJQJ^JaJ#h wJ5:CJ OJQJ\^JaJ h wJ5CJ OJQJ\^JaJ !"    $ % & D $$Ifa$^ '8^8`` ^` h^h`$a$:  $ % & . / 0 C D E ~  ǵqj\q\qNq9)jh&!5CJOJQJU\^JaJhkM CJOJQJ^JaJh&!CJOJQJ^JaJ h5\hCJOJQJ^JaJ h\YhCJOJQJ^JaJ h5CJOJQJ\^JaJ&h\Yh5CJOJQJ\^JaJhX&CJOJQJ^JaJh{h{CJOJQJ^JaJ#jh{CJOJQJU^JaJ/j\h h CJOJQJU^JaJD E m u ~ ( {rrrrrmrFf $$Ifa$ $Ifgdv$Iftkd$$Ifd44h|)(   0(4 daf4p      $ & ( * > @ B L N P R f h j t v x z ԿnS5jh>eh&!5CJOJQJU\^JaJ5jh>eh&!5CJOJQJU\^JaJ5jh>eh&!5CJOJQJU\^JaJ4jh 5CJOJQJU\^JaJmHnHu)jh&!5CJOJQJU\^JaJ5jh>eh&!5CJOJQJU\^JaJ h&!5CJOJQJ\^JaJ( P x $ & N v "JLt HpFf3 $$Ifa$gdttFf{ $$Ifa$gd>e $$Ifa$ $$Ifa$gdv    " $ ܬǑdǑIǑ5j h>eh&!5CJOJQJU\^JaJ5jv h>eh&!5CJOJQJU\^JaJ#hBh&!CJOJQJ\^JaJ4jh 5CJOJQJU\^JaJmHnHu5jh>eh&!5CJOJQJU\^JaJ)jh&!5CJOJQJU\^JaJ h&!5CJOJQJ\^JaJ#h&!h&!CJOJQJ\^JaJ$ & ( < > @ J L N P d f h r t v x ̱ݖ{ݖ`ݖE5j0h>eh&!5CJOJQJU\^JaJ5jh>eh&!5CJOJQJU\^JaJ5j@h>eh&!5CJOJQJU\^JaJ4jh 5CJOJQJU\^JaJmHnHu5jh>eh&!5CJOJQJU\^JaJ h&!5CJOJQJ\^JaJ)jh&!5CJOJQJU\^JaJh&!CJOJQJ^JaJ  "$8:<FHJппппeппJп5jh>eh&!5CJOJQJU\^JaJ5j h>eh&!5CJOJQJU\^JaJ#hBh&!CJOJQJ\^JaJ5jh>eh&!5CJOJQJU\^JaJ#h&!h&!CJOJQJ\^JaJ h&!5CJOJQJ\^JaJ)jh&!5CJOJQJU\^JaJ4jh 5CJOJQJU\^JaJmHnHuJLNbdfprtv̱ݖ{ݖ`ݖE5jh>eh&!5CJOJQJU\^JaJ5jph>eh&!5CJOJQJU\^JaJ5jh>eh&!5CJOJQJU\^JaJ4jh 5CJOJQJU\^JaJmHnHu5jh>eh&!5CJOJQJU\^JaJ h&!5CJOJQJ\^JaJ)jh&!5CJOJQJU\^JaJh&!CJOJQJ^JaJ   "68:DFHJ^`blnpппппeппJп5jPh>eh&!5CJOJQJU\^JaJ5jh>eh&!5CJOJQJU\^JaJ#hBh&!CJOJQJ\^JaJ5j`h>eh&!5CJOJQJU\^JaJ#h&!h&!CJOJQJ\^JaJ h&!5CJOJQJ\^JaJ)jh&!5CJOJQJU\^JaJ4jh 5CJOJQJU\^JaJmHnHuprtvx,VXw}h^h^gd>e ^` ^` h^h`gd>e`Ffprtx*,.0DFHRTV^vx|wһkWC5h=CJOJQJ^JaJ&h=h=5CJOJQJ\^JaJ&h h 5CJOJQJ\^JaJ,hM5h{6B*CJOJQJ^JaJph)jh 56B*UmHnHphu*j8hM5h56B*UphhM5h56B*ph$jhM5h56B*Uphh>eh{huCJOJQJ^JaJh{CJOJQJ^JaJh&!CJOJQJ^JaJwx|}~  ߯ߞߐ}oY}D})jh 56B*UmHnHphu*jhM5hM556B*UphhM5hM556B*ph$jhM5hM556B*Uphh>eCJOJQJ^JaJ h{6CJOJQJ]^JaJ/j h h CJOJQJU^JaJ/jh h CJOJQJU^JaJh{CJOJQJ^JaJ#jh{CJOJQJU^JaJ $&nz"|~Ƹ⦔xxcR:c/j$h:LC5CJOJQJU\^JaJ h{5CJOJQJ\^JaJ)jh{5CJOJQJU\^JaJhmCJOJQJ^JaJhTUCJOJQJ^JaJ#h\YhTU5CJOJQJ^JaJ#h\Yh\Y5CJOJQJ^JaJhM5CJOJQJ^JaJh6ZCJOJQJ^JaJhmVCJOJQJ^JaJh{CJOJQJ^JaJhwh{B*CJaJph "$&lnJ$zytkd $$Ifd44h4'%   04 daf4p  $$Ifa$h^hz|"Pxz NvxLtvFfU7 $$Ifa$gdt]Ff0Ff) $$Ifa$gdw $$Ifa$Ff"пппf咁TCп h>e5CJOJQJ\^JaJ#hBhwCJOJQJ\^JaJ5j%h>ehw5CJOJQJU\^JaJ hw5CJOJQJ\^JaJ)jhw5CJOJQJU\^JaJ/jf%h:LC5CJOJQJU\^JaJ h{5CJOJQJ\^JaJ)jh{5CJOJQJU\^JaJ4jh 5CJOJQJU\^JaJmHnHu "$8:<FHJNPRfhjtvxҷҦeSҦ;ҷҦ/jF'h:LC5CJOJQJU\^JaJ#hBhGCJOJQJ\^JaJ5j&hGhtt5CJOJQJU\^JaJ hG5CJOJQJ\^JaJ)jhG5CJOJQJU\^JaJ h{5CJOJQJ\^JaJ4jh 5CJOJQJU\^JaJmHnHu)jh{5CJOJQJU\^JaJ/jV&h:LC5CJOJQJU\^JaJxz|̴ݙ́ݙl[@ll[5j,h>ehw5CJOJQJU\^JaJ hw5CJOJQJ\^JaJ)jhw5CJOJQJU\^JaJ/j<,h:LC5CJOJQJU\^JaJ4jh 5CJOJQJU\^JaJmHnHu/j+h:LC5CJOJQJU\^JaJ h{5CJOJQJ\^JaJ)jh{5CJOJQJU\^JaJh{CJOJQJ^JaJ "68:DFHLNPdܯǔnSnA#hBhGCJOJQJ\^JaJ5j-hGhG5CJOJQJU\^JaJ hG5CJOJQJ\^JaJ)jhG5CJOJQJU\^JaJ4jh 5CJOJQJU\^JaJmHnHu/j*-h:LC5CJOJQJU\^JaJ)jh{5CJOJQJU\^JaJ h{5CJOJQJ\^JaJ#hBhwCJOJQJ\^JaJdfhrtvxzҷҦҦҷҦҦhҷҦSB hX5CJOJQJ\^JaJ)jhX5CJOJQJU\^JaJ/j 3h:LC5CJOJQJU\^JaJ/j2h:LC5CJOJQJU\^JaJh{CJOJQJ^JaJ h{5CJOJQJ\^JaJ4jh 5CJOJQJU\^JaJmHnHu)jh{5CJOJQJU\^JaJ/j.h:LC5CJOJQJU\^JaJ  4ϴϣkSkk>- ht]5CJOJQJ\^JaJ)jht]5CJOJQJU\^JaJ/j3h:LC5CJOJQJU\^JaJ)jh{5CJOJQJU\^JaJ h{5CJOJQJ\^JaJ#hBhXCJOJQJ\^JaJ hX5CJOJQJ\^JaJ4jh 5CJOJQJU\^JaJmHnHu)jhX5CJOJQJU\^JaJ5j3h>ehX5CJOJQJU\^JaJ468BDFJLNbdfprtv~ϴϣkSkkEA=5howhkM 5h{h,h{CJOJQJ^JaJ/j4h:LC5CJOJQJU\^JaJ)jh{5CJOJQJU\^JaJ h{5CJOJQJ\^JaJ#hBht]CJOJQJ\^JaJ ht]5CJOJQJ\^JaJ4jh 5CJOJQJU\^JaJmHnHu)jht]5CJOJQJU\^JaJ5jp4ht]htt5CJOJQJU\^JaJvxz|~*TV|>? $$Ifa$ hgdQ^gd6c ^` ^`gdh gd&`(*,.BDFPRTV\|~|~ɳמׇudSuAu#jh{CJOJQJU^JaJ h=5CJOJQJ\^JaJ h{5CJOJQJ\^JaJh{CJOJQJ^JaJh&,h&h{B*CJOJQJ\^JaJph)jh 56B*UmHnHphu*jf9hM5hM556B*UphhM5hM556B*ph$jhM5hM556B*Uphh>eh{howhkM how5?B !)ǯǡǡǓǁrdVHh&!CJOJQJ^JaJhy6CJOJQJ^JaJhQCJOJQJ^JaJh wJCJH*OJQJ^JaJ#h6ch6c5CJOJQJ^JaJh6cCJOJQJ^JaJh wJCJOJQJ^JaJ/jN:h h CJOJQJU^JaJh{CJOJQJ^JaJ#jh{CJOJQJU^JaJ/j9h h CJOJQJU^JaJ*Fc $$Ifa$tkd:$$Ifd44R&#   04 da4f4p )*deop  $&(246:>@ĬՑyՑhVG3&jhy6CJOJQJU\^JaJhy6CJOJQJ\^JaJ#hBht]CJOJQJ\^JaJ ht]5CJOJQJ\^JaJ/j=h:LC5CJOJQJU\^JaJ4jh 5CJOJQJU\^JaJmHnHu/j<=h:LC5CJOJQJU\^JaJ h{5CJOJQJ\^JaJ)jh{5CJOJQJU\^JaJh{CJOJQJ^JaJh{CJaJcdj0''' $$Ifa$kd;$$Ifd44\ .R& T$   (04 da4f4p(@TVXbdhjl©𘃘kP8P/j?h:LC5CJOJQJU\^JaJ4jh 5CJOJQJU\^JaJmHnHu/j>h:LC5CJOJQJU\^JaJ)jh{5CJOJQJU\^JaJ h{5CJOJQJ\^JaJ1jh CJOJQJU\^JaJmHnHu&jhy6CJOJQJU\^JaJ2j,>hy6hvCJOJQJU\^JaJhy6CJOJQJ\^JaJ ̾̑vaP8avaP/jAhy65CJOJQJU\^JaJ hy65CJOJQJ\^JaJ)jhy65CJOJQJU\^JaJ4jh 5CJOJQJU\^JaJmHnHu/j3Ah:LC5CJOJQJU\^JaJ)jh{5CJOJQJU\^JaJh{CJOJQJ^JaJ h{5CJOJQJ\^JaJ#hBht]CJOJQJ\^JaJ ht]5CJOJQJ\^JaJL)kd?$$Ifd4\ .R& T$  (04 da4f4p( $$Ifa$ "68:DFJLNbdfprtvްʗކqYq>qq4jh 5CJOJQJU\^JaJmHnHu/jBh:LC5CJOJQJU\^JaJ)jh{5CJOJQJU\^JaJ h{5CJOJQJ\^JaJ1jh CJOJQJU\^JaJmHnHu2j#Bhy6hy6CJOJQJU\^JaJ&jhy6CJOJQJU\^JaJhy6CJOJQJ\^JaJ#hBhy6CJOJQJ\^JaJLt)kdC$$Ifd4\ .R& T$  (04 da4f4p( $$Ifa$ҷҦu҃]ҷ҃H7 hy65CJOJQJ\^JaJ)jhy65CJOJQJU\^JaJ/j*Eh:LC5CJOJQJU\^JaJh{CJOJQJ^JaJ h{5CJOJQJ\^JaJ#hBht]CJOJQJ\^JaJ ht]5CJOJQJ\^JaJ4jh 5CJOJQJU\^JaJmHnHu)jh{5CJOJQJU\^JaJ/jCh:LC5CJOJQJU\^JaJ     & ( , . ҷҦqWq>q- h{5CJOJQJ\^JaJ1jh CJOJQJU\^JaJmHnHu2jFhy6hy6CJOJQJU\^JaJ&jhy6CJOJQJU\^JaJhy6CJOJQJ\^JaJ#hBhy6CJOJQJ\^JaJ hy65CJOJQJ\^JaJ4jh 5CJOJQJU\^JaJmHnHu)jhy65CJOJQJU\^JaJ/jEhy65CJOJQJU\^JaJ. V )kd|G$$Ifd4\ .R& T$  (04 da4f4p( $$Ifa$. 0 D F H R T V X l n p z | َ|n`RD6hexCJOJQJ^JaJhjCJOJQJ^JaJh10VCJOJQJ^JaJh%<CJOJQJ^JaJh{CJOJQJ^JaJ#hBht]CJOJQJ\^JaJ/jGh:LC5CJOJQJU\^JaJ4jh 5CJOJQJU\^JaJmHnHu/jFh:LC5CJOJQJU\^JaJ h{5CJOJQJ\^JaJ)jh{5CJOJQJU\^JaJ u#v##d$%%%t&& ' ''''' $$Ifa$gdvgd30 & FgdE ^` h^h` ^gdt] ^` ^`gdex !!!!w"x"""#.#@#G#u#v#x######d$f$$䗓}oW}o}o/jIh h CJOJQJU^JaJh{CJOJQJ^JaJ#jh{CJOJQJU^JaJh{h6chg3CJOJQJ^JaJhkM CJOJQJ^JaJh wJCJOJQJ^JaJ jhexCJOJQJ^JaJ#hLchex>*CJOJQJ^JaJhexCJOJQJ^JaJhjCJOJQJ^JaJ$$$%B%%%%%%%%%%%&&t&u&&ǹǫǘt_N= h75CJOJQJ\^JaJ h{5CJOJQJ\^JaJ)jh 56B*UmHnHphu*jJhM5hM556B*UphhM5hM556B*ph$jhM5hM556B*Uphht]CJOJQJ^JaJhQCJOJQJ^JaJh{CJOJQJ^JaJ#jh{CJOJQJU^JaJ/jIh h CJOJQJU^JaJ&&&&&&&&&& 'k'l'm'n''''''''x(((ǵǝǙ{j\U\G\hkM CJOJQJ^JaJ h&!5\h&!CJOJQJ^JaJ h\Yh&!CJOJQJ^JaJ#h30h&!5CJOJQJ^JaJhZ5hA,hZh{/jJh h CJOJQJU^JaJ#h{5>*CJOJQJ\^JaJh{CJOJQJ^JaJ#jh{CJOJQJU^JaJ/jyJh h CJOJQJU^JaJ''''' (<(x(((()uuuiiduFf_N $$Ifa$gdkM $$Ifa$gdv $IfgdvtkdaK$$Ifd44h")'   0'4 daf4p  (() ) )))))0)2)4)>)@)B)D)X)Z)\)f)h)j)l)))))))پوmR5jRh>eh&!5CJOJQJU\^JaJ5jQh>eh&!5CJOJQJU\^JaJ5j'Qh>eh&!5CJOJQJU\^JaJ4jh 5CJOJQJU\^JaJmHnHu5jPh>eh&!5CJOJQJU\^JaJ h&!5CJOJQJ\^JaJ)jh&!5CJOJQJU\^JaJ)B)j))))**@*h****+<+>+f++++,:,b,d,f,h,j,Ff|eFf]Ff V $$Ifa$gdv))))))))))))))))))))******ܬǑdǑIǑ5jSh>eh&!5CJOJQJU\^JaJ5jSh>eh&!5CJOJQJU\^JaJ#hBh&!CJOJQJ\^JaJ4jh 5CJOJQJU\^JaJmHnHu5jRh>eh&!5CJOJQJU\^JaJ)jh&!5CJOJQJU\^JaJ h&!5CJOJQJ\^JaJ#h&!h&!CJOJQJ\^JaJ***.*0*2*<*>*@*B*V*X*Z*d*f*h*j*~**********̱ݖ{ݖ`ݖE5jYh>eh&!5CJOJQJU\^JaJ5jIYh>eh&!5CJOJQJU\^JaJ5jXh>eh&!5CJOJQJU\^JaJ4jh 5CJOJQJU\^JaJmHnHu5jYXh>eh&!5CJOJQJU\^JaJ h&!5CJOJQJ\^JaJ)jh&!5CJOJQJU\^JaJh&!CJOJQJ^JaJ****************+++++++*+,+.+8+:+<+ппппeппJп5j)[h>eh&!5CJOJQJU\^JaJ5jZh>eh&!5CJOJQJU\^JaJ#hBh&!CJOJQJ\^JaJ5j9Zh>eh&!5CJOJQJU\^JaJ#h&!h&!CJOJQJ\^JaJ h&!5CJOJQJ\^JaJ)jh&!5CJOJQJU\^JaJ4jh 5CJOJQJU\^JaJmHnHu<+>+@+T+V+X+b+d+f+h+|+~++++++++++++++++̱ݖ{ݖ`ݖE5jyah>eh&!5CJOJQJU\^JaJ5jah>eh&!5CJOJQJU\^JaJ5j`h>eh&!5CJOJQJU\^JaJ4jh 5CJOJQJU\^JaJmHnHu5j`h>eh&!5CJOJQJU\^JaJ h&!5CJOJQJ\^JaJ)jh&!5CJOJQJU\^JaJh&!CJOJQJ^JaJ++++++++++, , ,,,,(,*,,,6,8,:,<,P,R,T,^,`,b,ппппeппJп5jbh>eh&!5CJOJQJU\^JaJ5jibh>eh&!5CJOJQJU\^JaJ#hBh&!CJOJQJ\^JaJ5jah>eh&!5CJOJQJU\^JaJ#h&!h&!CJOJQJ\^JaJ h&!5CJOJQJ\^JaJ)jh&!5CJOJQJU\^JaJ4jh 5CJOJQJU\^JaJmHnHub,d,f,j,--------.&(&(Dҿqo^M;#jh{CJOJQJU^JaJ h75CJOJQJ\^JaJ h{5CJOJQJ\^JaJU)hW?hW?B*CJOJQJ^JaJph)jh 56B*UmHnHphu*jghM5hM556B*UphhM5hM556B*ph$jhM5hM556B*Uphh{hZ`CJOJQJ^JaJh{CJOJQJ^JaJh&!CJOJQJ^JaJj,--.&~ "ʜ̜Μ $$Ifa$gdv^ 88^8` ^`h^hgdW?` c. Blood collection: Will survival blood collections be obtained from animals following immunization or as a  pre-bleed prior to immunization?  FORMCHECKBOX  No. Proceed to item 4.  FORMCHECKBOX  Yes. Complete items 3.c.i) and ii); then proceed to item 4. i) Complete the following table. Include any  pre-bleeds prior to immunizations. TABLE 5  BLOOD COLLECTIONSite of blood collection* Amount of blood collected expressed as volume (mL)/ and % of body weight (assume 1 ml = 1 gram)Number of blood collectionsInterval between collections FORMTEXT       FORMTEXT       mL/  FORMTEXT       % FORMTEXT       FORMTEXT       weeks FORMTEXT       FORMTEXT       mL/  FORMTEXT       % FORMTEXT       FORMTEXT       weeks FORMTEXT       FORMTEXT       mL/  FORMTEXT       % FORMTEXT       FORMTEXT       weeks * To approximate acceptable blood collection volumes, assume the total blood volume of a healthy animal as 7% of its body weight, and that 10% of the total blood volume can be collected every 2 weeks without causing significant physiological change. (Example: acceptable blood volume for a 30 g mouse ( 0.07 X 30 g X 0.10 = .21 mL.) Blood volumes in excess of 10% will be considered with scientific justification. Typically the maximum blood available for a terminal procedure is 50% of blood volume - MUST be taken with the animal under anesthesia. ii) Will anesthetics, tranquilizers, or analgesics be used prior to blood collection?  FORMCHECKBOX  No. Justify the omission of pain-relieving agents below; then proceed to item 4.  FORMCHECKBOX  Yes. Describe the administration of pain-relieving agents including dose (mg/kg), volume (mL), route, and frequency/duration below; then proceed to item 4.  FORMTEXT       4. Terminal blood collection: Will animals used for antibody production be exsanguinated as a method of euthanasia?  FORMCHECKBOX  No. Go to item 5.  FORMCHECKBOX  Yes. Complete items 4.a, b., and c. below, then go to item 5. a. Describe the method of exsanguination.  FORMTEXT       b. Will anesthetics, tranquilizers, or analgesics be used prior to exsanguination?  FORMCHECKBOX  No. Justify the omission of pain-relieving agents below; then proceed to item 5.  FORMTEXT        FORMCHECKBOX  Yes. Describe the administration of pain-relieving agents including dose (mg/kg), volume (ml), route, and frequency/duration here; then proceed to item 5.  FORMTEXT       c. How will you make sure that the animals are dead following blood withdrawal?  FORMTEXT       5. How will the antigens or cell lines listed in items 1.b., 2.b., and 3.a. be screened to make sure they do not harbor infectious agents that could infect other laboratory animals or people after injection?  FORMTEXT       Return to the main CRP form and continue with item P. Additional Comments  FORMTEXT           PAGE  PAGE 1 Appendix 1  Antibody Production (Dec 2003) DFH~ԛ֛"$`bdfʜΜܜ8:<ǯǡǡǝdžtfWHfhLcCJH*OJQJ^JaJh"CJH*OJQJ^JaJhy6CJOJQJ^JaJ#h6chy65CJOJQJ^JaJhy65CJOJQJ^JaJhAh{h`Zh"CJOJQJ^JaJ/jhh h CJOJQJU^JaJh{CJOJQJ^JaJ#jh{CJOJQJU^JaJ/j=hh h CJOJQJU^JaJ84n~~~~ $$Ifa$gdvtkd)i$$Ifd44R&#   04 da4f4p prĞȞʞޞĬՑyՑgXDX&jhy6CJOJQJU\^JaJhy6CJOJQJ\^JaJ#hBhy6CJOJQJ\^JaJ/jlhy65CJOJQJU\^JaJ4jh 5CJOJQJU\^JaJmHnHu/jkhy65CJOJQJU\^JaJ hy65CJOJQJ\^JaJ)jhy65CJOJQJU\^JaJhy6CJOJQJ^JaJhy6CJaJnp0$$$ $$Ifa$gdvkdj$$Ifd44\ .R& T$   (04 da4f4p(ޞ 246@BDҹҪlQ9Q/jmhy65CJOJQJU\^JaJ4jh 5CJOJQJU\^JaJmHnHu/j mhy65CJOJQJU\^JaJ)jhy65CJOJQJU\^JaJ hy65CJOJQJ\^JaJhy6CJOJQJ\^JaJ1jh CJOJQJU\^JaJmHnHu&jhy6CJOJQJU\^JaJ2jlhy6hy6CJOJQJU\^JaJDNPRThjlvxz|ιܡܹn_K_&jhy6CJOJQJU\^JaJhy6CJOJQJ\^JaJ/jphy65CJOJQJU\^JaJ4jh 5CJOJQJU\^JaJmHnHu/johy65CJOJQJU\^JaJ)jhy65CJOJQJU\^JaJhy6CJOJQJ^JaJ hy65CJOJQJ\^JaJ#hBhy6CJOJQJ\^JaJPRz֟&kdm$$Ifd4\ .R& T$  (04 da4f4p( $$Ifa$gdvŸğΟПԟ֟؟"$&ҹҪlQ9Q/jzqhy65CJOJQJU\^JaJ4jh 5CJOJQJU\^JaJmHnHu/jqhy65CJOJQJU\^JaJ)jhy65CJOJQJU\^JaJ hy65CJOJQJ\^JaJhy6CJOJQJ\^JaJ1jh CJOJQJU\^JaJmHnHu&jhy6CJOJQJU\^JaJ2jphy6hy6CJOJQJU\^JaJ֟24\&kdq$$Ifd4\ .R& T$  (04 da4f4p( $$Ifa$gdv&0246JLNXZ\^rtvιܡܹn_K_&jhy6CJOJQJU\^JaJhy6CJOJQJ\^JaJ/jthy65CJOJQJU\^JaJ4jh 5CJOJQJU\^JaJmHnHu/jshy65CJOJQJU\^JaJ)jhy65CJOJQJU\^JaJhy6CJOJQJ^JaJ hy65CJOJQJ\^JaJ#hBhy6CJOJQJ\^JaJΠРҠܠޠҹҪlQ9Q/jmuhy65CJOJQJU\^JaJ4jh 5CJOJQJU\^JaJmHnHu/jthy65CJOJQJU\^JaJ)jhy65CJOJQJU\^JaJ hy65CJOJQJ\^JaJhy6CJOJQJ\^JaJ1jh CJOJQJU\^JaJmHnHu&jhy6CJOJQJU\^JaJ2jthy6hy6CJOJQJU\^JaJ\&kdu$$Ifd4\ .R& T$  (04 da4f4p( $$Ifa$gdv "<>*4JTz| rtx|vhvWIIEh`ZhvQCJOJQJ^JaJ jhLcCJOJQJ^JaJhexCJOJQJ^JaJ#hLchLc>*CJOJQJ^JaJhC0CJOJQJ^JaJhLcCJOJQJ^JaJh"CJOJQJ^JaJh10VCJOJQJ^JaJh CJOJQJ^JaJhy6CJOJQJ^JaJ hy65CJOJQJ\^JaJ#hBhy6CJOJQJ\^JaJtx(R|~rfh 8^8`gde]Sh^h 8^8gd`Z h^h`gd`Z ^` 8^`gdt]^gdvQ >^`>gd"|(*FHJħЧPRTVjlnxzܬܞܐ}oY}D})jh 56B*UmHnHphu*jnxhM5hM556B*UphhM5hM556B*ph$jhM5hM556B*Uphht]CJOJQJ^JaJhe]SCJOJQJ^JaJ/jwh h CJOJQJU^JaJ/jwh h CJOJQJU^JaJh{CJOJQJ^JaJ#jh{CJOJQJU^JaJh{z|~rt©ީfԪĽ˫miVHhM5hM556B*ph$jhM5hM556B*Uphht]/jXyh h CJOJQJU^JaJ/jxh h CJOJQJU^JaJh{CJOJQJ^JaJ#jh{CJOJQJU^JaJ h75\ h{5\h{h:'h6ZCJOJQJ^JaJh6Z6B*CJ\aJphh{6B*CJ\aJphԪ֪ت^`tvx׾יnc_יhttj,{h U!ho3ho3B*OJQJ^Jphho3*jzhM5hM556B*UphhM5hM556B*phjBzh Ujh{Uht' h{)jh 56B*UmHnHphu$jhM5hM556B*Uph*jyhM5hM556B*Uph^ڮܮgd>H & F ^`gdY h^h`^  88^8gdB  88^8gdo3  88^8gdtt 8^8`gde]S8^8gdtt Ȯʮ̮֮خڮ~ΰ԰׾׬׾׬r׈dVHhA,CJOJQJ^JaJh>HCJOJQJ^JaJhe]SCJOJQJ^JaJ*j|hM5hM556B*Uphh{CJOJQJ^JaJ*j|hM5hM556B*UphhM5hM556B*phhtth{)jh 56B*UmHnHphu$jhM5hM556B*Uph*j{hM5hM556B*UphBDFZ\^hjlnprȺȏ}l`K`<.h>HCJOJQJ^JaJh>HhA,B*CJaJph)hA,hA,B*CJOJQJ^JaJphhA,B*CJaJph hA,hA,CJOJQJ^JaJ#hLhL5CJOJQJ^JaJ)jh 56B*UmHnHphu*j|hM5hM556B*UphhM5hM556B*ph$jhM5hM556B*Uph hA,5>*䴳ϴ&>>5>*䴳ϴٱԱٱʱı>±ıȱʱֱرڱܱޱ8:<h>HCJOJQJ^JaJhw0JmHnHuh h 0Jjh 0JUhl_jhl_UıƱȱޱ68:<gd>H$a$gdCb$&`#$a$gdCb &`#$gdCb -...()()()..)() 0P/ =!"#$% 8$2 00P/ =!"#$% / 0P/ =!"#$% 2 00P/ =!"#$% / 0P/ =!"#$% 2 00P/ =!"#$% / 0P/ =!"#$% 2 00P/ =!"#$% / 0P/ =!"#$% 2 00P/ =!"#$% / 0P/ =!"#$% / 0P/ =!"#$% tDeCheck1tDeCheck2tDeCheck3tDeCheck4$$If!vh5(#v(:V d44   0(,5(/  / 44 daf4p $$$If!vh555_5555@ #v#v#v_#v#v#v#v@ :V d44  F0(,555_5555@ / /  / /  / / / 44 daf4pFNkd$$Ifd44֞h <|)_@   F0(4 daf4pFxDText174xDText175xDText175xDText175xDText176xDText177xDText177$$If!vh555_5555@ #v#v#v_#v#v#v#v@ :V d4D F0(,555_5555@ / /  / / / / 44 daf4pFKkdf $$Ifd4D֞h <|)_@  F0(4 daf4pFxDText174xDText175xDText175xDText175xDText176xDText177xDText177!$$If!vh555_5555@ #v#v#v_#v#v#v#v@ :V d4 F0(,555_5555@ / / / / / / / 44 daf4pFKkd$$Ifd4֞h <|)_@  F0(4 daf4pFxDText174xDText175xDText175xDText175xDText176xDText177xDText177!$$If!vh555_5555@ #v#v#v_#v#v#v#v@ :V d4 F0(,555_5555@ / /  / / / /  / 44 daf4pFKkd$$Ifd4֞h <|)_@  F0(4 daf4pFtDText3tDeCheck5tDeCheck6tDText3$$If!vh5%#v%:V d44   0,5%/  / 44 daf4p $$If!vh5g55555:#vg#v#v#v#v#v::V d44 <0,5g55555:/ /  / /  / / / 44 daf4p<kd $$Ifd44ֈh_ V!4'g: <04 daf4p<xDText120xDText121xDText172xDText123xDText179xDText125$$If!vh5g55555:#vg#v#v#v#v#v::V d4 <0,5g55555:/ / / / / / / 44 daf4p<kd'$$Ifd4ֈh_ V!4'g: <04 daf4p<vDText37vDText38xDText172vDText40xDText179vDText42$$If!vh5g55555:#vg#v#v#v#v#v::V d4 <0,5g55555:/ / / / / / / 44 daf4p<kd.$$Ifd4ֈh_ V!4'g: <04 daf4p<vDText43vDText44xDText172vDText46xDText180vDText48$$If!vh5g55555:#vg#v#v#v#v#v::V d4 <0,5g55555:/ /  / / / /  / 44 daf4p<kd^5$$Ifd4ֈh_ V!4'g: <04 daf4p<tDText3tDeCheck7tDeCheck8$$If4!vh5##v#:V d44   0,5#/  / 44 da4f4p $$If4!vh55 5T5$ #v#v #vT#v$ :V d44  (0,55 5T5$ / /  / /  / / / 44 da4f4p(xDText138xDText139xDText187xDText140xDText141$$If4!vh55 5T5$ #v#v #vT#v$ :V d4 (0,55 5T5$ / / / / / / / 44 da4f4p(xDText142xDText139xDText187xDText144xDText145$$If4!vh55 5T5$ #v#v #vT#v$ :V d4 (0,55 5T5$ / / / / / / / 44 da4f4p(vDText58xDText139xDText187vDText60vDText61$$If4!vh55 5T5$ #v#v #vT#v$ :V d4 (0,55 5T5$ / /  / / / /  / 44 da4f4p(tDeCheck9vDeCheck10tDText3tDeCheck7tDeCheck8$$If!vh5'#v':V d44   0',5'/  / 44 daf4p $$$If!vh555_5555 #v#v#v_#v#v#v#v :V d44  F0',555_5555 / /  / /  / / / 44 daf4pFNkd9L$$Ifd44֞h <")_   F0'4 daf4pFxDText174xDText175xDText175xDText175xDText176xDText177xDText177$$If!vh555_5555 #v#v#v_#v#v#v#v :V d4D F0',555_5555 / /  / / / / 44 daf4pFKkdS$$Ifd4D֞h <")_  F0'4 daf4pFxDText174xDText175xDText175xDText175xDText176xDText177xDText177!$$If!vh555_5555 #v#v#v_#v#v#v#v :V d4 F0',555_5555 / / / / / / / 44 daf4pFKkd[$$Ifd4֞h <")_  F0'4 daf4pFxDText174xDText175xDText175xDText175xDText176xDText177xDText177!$$If!vh555_5555 #v#v#v_#v#v#v#v :V d4 F0',555_5555 / /  / / / /  / 44 daf4pFKkdYc$$Ifd4֞h <")_  F0'4 daf4pFtDText3vDeCheck15vDeCheck16$$If4!vh5##v#:V d44   0,5#/  / 44 da4f4p $$If4!vh55 5T5$ #v#v #vT#v$ :V d44  (0,55 5T5$ / /  / /  / / / 44 da4f4p(xDText138xDText139xDText187xDText140xDText141$$If4!vh55 5T5$ #v#v #vT#v$ :V d4 (0,55 5T5$ / / / / / / / 44 da4f4p(xDText142xDText139xDText187xDText144xDText145$$If4!vh55 5T5$ #v#v #vT#v$ :V d4 (0,55 5T5$ / / / / / / / 44 da4f4p(vDText58xDText139xDText187vDText60vDText61$$If4!vh55 5T5$ #v#v #vT#v$ :V d4 (0,55 5T5$ / /  / / / /  / 44 da4f4p(vDeCheck13vDeCheck14tDText3vDeCheck11vDeCheck12tDText3vDeCheck17tDText3vDeCheck18tDText3tDText3tDText3tDText3B@B Normal 1$7$8$_HmH sH tH T@T Heading 1$$@&a$5CJOJQJ\^JaJDA@D Default Paragraph FontRi@R  Table Normal4 l4a (k(No List 4 @4 Footer  !.)@. Page NumberXC@X Body Text Indent ^CJOJQJ^JaJxR@"x Body Text Indent 2& p@ ^`CJOJQJ^JaJlS@2l Body Text Indent 3 @ `^``CJOJQJ^JaJ6U@A6 Hyperlink >*B*phFV@QF FollowedHyperlink >*B* ph4@b4 CbHeader  !HrH &! Balloon TextCJOJQJ^JaJ&I  D1b#$/c-^(!"$%&DEmu~(<Sj~%&:Nbyw} 0 M u   3 G H \ p   1 E F G H I J I v   : ; T 1E_`t'ABCDEqr.p8atu0D[r-./01  abc~34Hv*Xlu%:;<=/ 0 [ o p +!?!@!!""U"i"j"O#P###################################$$0(00000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000 0000 0 0 0 0 0 0 0 00 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 00000000000000 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 00000000000000000000000000000000 00y00000000000000000000000000y00y00y00y00y00@0@0y00 OOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOR  $ Jpw xd4)@. $&()**<++b,DޞD&|zԪ< !"$%&)*+,-./124679;<>@ABDFGHIJKZ\^_acdfhijlmoD ( pzvcL ')j,n֟\<#'(0358:=?CEL[]`begknp:  &(4:<HNS_ejv|~ #&28:FLNZ`bntyw~      ( . 3 ? E H T Z \ h n p |      & , 1 = C I Y v '-1=CEQW`lrt %'39.>(.0<BDPV[gmr~%+4@FHTZ`lrv "(*6<BNTXdjlx~ u&28[ g m +!7!=!@!P!!!"U"a"g";#G#M####$G$G$G G$FFFFFFFFFFFFFFFFFFFFFFG G FFFFFFFFFFFFFFFFFFFFG G FFFFFFFFFFFFFFFG G FG G FFFFFFFFFFFFFFFFFFFFFFG G FFFFFFFFFFFFFFFG G FG G FG$FG$FFFF  R!!=Check1Check2Check3Check4Text6Text7Text174Text175Text176Text177Text29Text3Check5Check6Text30Text120Text121Text123Text179Text125Text37Text38Text40Text42Text43Text44Text46Text180Text48Text49Check7Check8Text138Text139Text187Text140Text141Text142Text144Text145Text58Text60Text61Check9Text164Check10Text163Check15Check16Check13Text165Check14Text162Check11Check12Text103Check17Text166Check18Text167Text104Tkw{   3 H \   1 I v 1E`'+.su#Y (!@!!S"$   !"#$%&'()*+,-./0123456789:;<'fj}~~  / F [ o  - D Z .DXs&:-?!t&[ *!Q!!U"$?Hgi*3fm $ I K   0 2      - 1 D I Z v .1DEX`st&':.?pu/0CDW[nr,4GH[`sv)*=BUXkl [ n O!Q!################$$El############$$33333&Em'(;<OSfj}~$&9:MNabuyw~     / 3 F H [ \ o p     - 1 D I Z v .1DEX`st&':.?pu/0CDW[nr,4GH[`sv)*=BUXkl!u&9[ n +!>!!"U"h";#N##################$$$############$$+/G{c >\&ݺ'<)b0}J2 LvUO̔@xz},p^`o(. ^`hH. pLp^p`LhH. @ @ ^@ `hH. ^`hH. L^`LhH. ^`hH. ^`hH. PLP^P`LhH.88^8`o(. ^`hH.  L ^ `LhH.   ^ `hH. xx^x`hH. HLH^H`LhH. ^`hH. ^`hH. L^`LhH.p0p^p`0o()0^`0o(.^`o(. ^`hH. pLp^p`LhH. @ @ ^@ `hH. ^`hH. L^`LhH. ^`hH. ^`hH. PLP^P`LhH.^`o(. ^`hH. pLp^p`LhH. @ @ ^@ `hH. ^`hH. L^`LhH. ^`hH. ^`hH. PLP^P`LhH.88^8`o(. ^`hH.  L ^ `LhH.   ^ `hH. xx^x`hH. HLH^H`LhH. ^`hH. ^`hH. L^`LhH.\O&'<)+/G}JvUOc xz}          Y                          6ic        yimwvHh kM zg%<t' X&:'($+A,30S2M5Z5y6\[8%;F;<#=W?p@GCB:LC-D>H wJfMSe]SnTTU10VmVDW\Y6Zs\Z`=bCbLc>e*jYYl"oIowowmDx{ `u}Qd"ttBL~Ng3rD,v %H,o3Z&Z8(9E%l_lu S2t]&!bjv/=[vQ6cg|AG06k+l8ex`ZYRj 0C077*X&DEmu~(<Sj~%&:Nby 0 M u   3 G H \ p   1 E F  : ; T 1E_`t'AB8tu0D[r-.c~34Hv*Xl$@&_ $P@P PPP$@PPPPP8@PP PD@P$PL@P(P*PUnknownGz Times New Roman5Symbol3& z Arial5& zaTahoma"hhˆFyfWr@Wr@!xxd##2QX?$+2 Appendix AB Lee M. DunnTimothy Staskiewicz(       Oh+'0 $ D P \ ht| Appendix AB Lee M. DunnNormalTimothy Staskiewicz3Microsoft Office Word@F#@V@ |@Wr ?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrtuvwxyz{|}~Root Entry Fֲ5Data sr}1TabledWordDocumentYSummaryInformation(DocumentSummaryInformation8-(CompObjqMsoDataStore Ӳ5ֲ5  !"#$&'(*+,./0123456789:;<=?ABC  FMicrosoft Office Word Document MSWordDocWord.Document.89qDocumentLibraryFormDocumentLibraryFormDocumentLibraryForm Բ:="ٳٱ://𳾲.DZԳ泾ڴǰٲ.ǰ/ǴڴھٴdzܳԳ/2006/ܲٴdzݳ"/>Document ID GeneratorSynchronous100011000Microsoft.Office.DocumentManagement, Version=15.0.0.0, Culture=neutral, PublicKeyToken=71e9bce111e9429cMicrexType> This value indicates the number of saves or revisions. The application is responsible for updating this value after each revision. t ref="dc:subject" minOccurs="0" maxOccurs="1"/> Occurs="1" type="xsd:string"/> This value indicates the number of saves or revisions. The application is responsible for updating this value after each revision. osoft.Office.DocumentManagement.Internal.DocIdHandlerDocument ID GeneratorSynchronous100021001Microsoft.Office.DocumentManagement, Version=15.0.0.0, Culture=neutral, PublicKeyToken=71e9bce111e9429cMicrosoft.Office.DocumentManagement.Internal.DocIdHandlerDocument ID GeneratorSynchronous100041002Microsoft.Office.DocumentManagement, Version=15.0.0.0, Culture=neutral, PublicKeyToken=71e9bce111e9429cMicrosoft.Office.DocumentManagement.Internal.DocIdHandlerDocument ID GeneratorSynchronous100061003Microsoft.Office.DocumentManagement, Version=15.0.0.0, Culture=neutral, PublicKeyToken=71e9bce111e9429cMicrosoft.Office.DocumentManagement.Internal.DocIdHandlerrl>Microsoft.Office.DocumentManagemen ceivers> ՜.+,D՜.+,@ hp   VA Hospital@#G  Appendix AB Title X(08Xt _AdHocReviewCycleID_EmailSubject _AuthorEmail_AuthorEmailDisplayName_ReviewingToolsShownOnce _dlc_DocId_dlc_DocIdItemGuid _dlc_DocIdUrlpu7Replacement appendices JMorrison@ric.eduMorrison, Johanna67Z3ZXSPZZWZ-509-4%ce5c6106-fe58-433c-baf2-ad3528a7f57d_http://www.ric.edu/iacuc/_layouts/15/DocIdRedir.aspx?ID=67Z3ZXSPZZWZ-509-4, 67Z3ZXSPZZWZ-509-4